For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Etubics Corporation

USPTO Granted Patents = 19

EPO Patents = 5

Forward Citations = 68

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Frank R Jones (19 out of 26 patents)

Joseph P Balint (14 out of 24 patents)

Elizabeth Gabitzsch (10 out of 10 patents)

4. Richard B Gayle (6 out of 6 patents)

5. Yvette Latchman (6 out of 7 patents)

6. Adrian Rice (6 out of 6 patents)

7. Richard B Gayle, Iii (3 out of 6 patents)

8. Richard B Iii Gayle (0 patent)

9. Richard B Iii Gayle (0 patent)

19 patents: Sort by Forward Citations

1. 12370250 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2025-07-29),

2. 11826417 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2023-11-28),

3. 11529408 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2022-12-20),

4. 11504423 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2022-11-22),

5. 11389521 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2022-07-19),

6. 11376316 - Breast cancer vaccines and methods of use thereof (2022-07-05),

7. 11369673 - HPV vaccines and methods of use thereof (2022-06-28),

8. 11352642 - Methods and compositions for combination immunotherapy (2022-06-07),

9. 11344613 - Sequential administration of a replication defective adenovirus vector in vaccination protocols (2022-05-31),

10. 11304998 - Combination immunotherapies comprising IL-15 superagonists (2022-04-19),

11. 11149087 - Methods and compositions for combination immunotherapy (2021-10-19),

12. 11116827 - Compositions and methods for tumor vaccination and immunotherapy involving HER antigens (2021-09-14),

13. 11104916 - Compositions and methods for alphavirus vaccination (2021-08-31),

14. 11020467 - Combination immunotherapies comprising IL-15 superagonists (2021-06-01),

15. 10835596 - Compositions and methods for flavivirus vaccination (2020-11-17),

Etubics Corporation, based in Seattle, WA, specializes in the development of innovative biopharmaceutical solutions. The company focuses on advancing therapeutic technologies, particularly in the fields of immunotherapy and regenerative medicine. By leveraging cutting-edge research, Etubics aims to address significant medical challenges and improve patient outcomes. Their commitment to scientific excellence positions them as a key player in the evolving landscape of healthcare and biotechnology.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

19 Patents

#107 in Seattle, WA

#371 in Washington

#17,113 in US

#32,592 in the World

Seattle, WA, United States of America

Etubics Corporation

Forward Citations = 68

7 inventors:

Frank R Jones (19 out of 26 patents)

Joseph P Balint (14 out of 24 patents)

Elizabeth Gabitzsch (10 out of 10 patents)

4. Richard B Gayle (6 out of 6 patents)

5. Yvette Latchman (6 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…